nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADK—Abacavir—acquired immunodeficiency syndrome	0.454	1	CbGbCtD
Vidarabine—Nelarabine—Abacavir—acquired immunodeficiency syndrome	0.148	0.351	CrCrCtD
Vidarabine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.133	0.316	CrCrCtD
Vidarabine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.0734	0.175	CrCrCtD
Vidarabine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0664	0.158	CrCrCtD
Vidarabine—DPP4—blood plasma—acquired immunodeficiency syndrome	0.00236	0.0679	CbGeAlD
Vidarabine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.00177	0.556	CrCbGaD
Vidarabine—ADK—retina—acquired immunodeficiency syndrome	0.00133	0.0384	CbGeAlD
Vidarabine—ADK—skin of body—acquired immunodeficiency syndrome	0.00117	0.0337	CbGeAlD
Vidarabine—ADA—lymphoid tissue—acquired immunodeficiency syndrome	0.00116	0.0334	CbGeAlD
Vidarabine—ADA—digestive system—acquired immunodeficiency syndrome	0.00115	0.033	CbGeAlD
Vidarabine—ADA—blood—acquired immunodeficiency syndrome	0.00109	0.0314	CbGeAlD
Vidarabine—ADA—bone marrow—acquired immunodeficiency syndrome	0.00106	0.0304	CbGeAlD
Vidarabine—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.00106	0.0304	CbGeAlD
Vidarabine—ADA—vagina—acquired immunodeficiency syndrome	0.00101	0.0291	CbGeAlD
Vidarabine—Glucosamine—IFNG—acquired immunodeficiency syndrome	0.001	0.313	CrCbGaD
Vidarabine—ADORA2A—blood—acquired immunodeficiency syndrome	0.000993	0.0286	CbGeAlD
Vidarabine—ADA—lung—acquired immunodeficiency syndrome	0.000957	0.0275	CbGeAlD
Vidarabine—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.000957	0.0275	CbGeAlD
Vidarabine—ADK—lymphoid tissue—acquired immunodeficiency syndrome	0.000948	0.0273	CbGeAlD
Vidarabine—DPP4—lymphoid tissue—acquired immunodeficiency syndrome	0.000919	0.0264	CbGeAlD
Vidarabine—DPP4—digestive system—acquired immunodeficiency syndrome	0.000908	0.0261	CbGeAlD
Vidarabine—ADK—blood—acquired immunodeficiency syndrome	0.000892	0.0257	CbGeAlD
Vidarabine—ADA—nervous system—acquired immunodeficiency syndrome	0.000886	0.0255	CbGeAlD
Vidarabine—DPP4—blood—acquired immunodeficiency syndrome	0.000865	0.0249	CbGeAlD
Vidarabine—ADK—bone marrow—acquired immunodeficiency syndrome	0.000863	0.0248	CbGeAlD
Vidarabine—ADK—spinal cord—acquired immunodeficiency syndrome	0.000859	0.0247	CbGeAlD
Vidarabine—ADA—central nervous system—acquired immunodeficiency syndrome	0.000853	0.0245	CbGeAlD
Vidarabine—DPP4—bone marrow—acquired immunodeficiency syndrome	0.000837	0.0241	CbGeAlD
Vidarabine—ADK—vagina—acquired immunodeficiency syndrome	0.000827	0.0238	CbGeAlD
Vidarabine—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.000806	0.0232	CbGeAlD
Vidarabine—DPP4—vagina—acquired immunodeficiency syndrome	0.000801	0.0231	CbGeAlD
Vidarabine—ADK—lung—acquired immunodeficiency syndrome	0.000782	0.0225	CbGeAlD
Vidarabine—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.000776	0.0223	CbGeAlD
Vidarabine—DPP4—lung—acquired immunodeficiency syndrome	0.000758	0.0218	CbGeAlD
Vidarabine—ADK—nervous system—acquired immunodeficiency syndrome	0.000724	0.0208	CbGeAlD
Vidarabine—DPP4—nervous system—acquired immunodeficiency syndrome	0.000702	0.0202	CbGeAlD
Vidarabine—ADK—central nervous system—acquired immunodeficiency syndrome	0.000697	0.0201	CbGeAlD
Vidarabine—ADA—brain—acquired immunodeficiency syndrome	0.000677	0.0195	CbGeAlD
Vidarabine—DPP4—central nervous system—acquired immunodeficiency syndrome	0.000676	0.0194	CbGeAlD
Vidarabine—ADA—lymph node—acquired immunodeficiency syndrome	0.000654	0.0188	CbGeAlD
Vidarabine—ADORA2A—brain—acquired immunodeficiency syndrome	0.000616	0.0177	CbGeAlD
Vidarabine—ADK—brain—acquired immunodeficiency syndrome	0.000553	0.0159	CbGeAlD
Vidarabine—DPP4—brain—acquired immunodeficiency syndrome	0.000537	0.0154	CbGeAlD
Vidarabine—ADK—lymph node—acquired immunodeficiency syndrome	0.000535	0.0154	CbGeAlD
Vidarabine—DPP4—lymph node—acquired immunodeficiency syndrome	0.000518	0.0149	CbGeAlD
Vidarabine—Glucosamine—TNF—acquired immunodeficiency syndrome	0.000419	0.131	CrCbGaD
Vidarabine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.00209	CcSEcCtD
Vidarabine—Cough—Indinavir—acquired immunodeficiency syndrome	0.000184	0.00209	CcSEcCtD
Vidarabine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000183	0.00208	CcSEcCtD
Vidarabine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000183	0.00207	CcSEcCtD
Vidarabine—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.00207	CcSEcCtD
Vidarabine—Pain—Stavudine—acquired immunodeficiency syndrome	0.000182	0.00207	CcSEcCtD
Vidarabine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.00207	CcSEcCtD
Vidarabine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.00207	CcSEcCtD
Vidarabine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.00206	CcSEcCtD
Vidarabine—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00206	CcSEcCtD
Vidarabine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000181	0.00205	CcSEcCtD
Vidarabine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.00204	CcSEcCtD
Vidarabine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00204	CcSEcCtD
Vidarabine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00018	0.00204	CcSEcCtD
Vidarabine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000179	0.00203	CcSEcCtD
Vidarabine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.00203	CcSEcCtD
Vidarabine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.00203	CcSEcCtD
Vidarabine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00203	CcSEcCtD
Vidarabine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000178	0.00202	CcSEcCtD
Vidarabine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.002	CcSEcCtD
Vidarabine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000176	0.002	CcSEcCtD
Vidarabine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.002	CcSEcCtD
Vidarabine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000176	0.00199	CcSEcCtD
Vidarabine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.00199	CcSEcCtD
Vidarabine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000175	0.00199	CcSEcCtD
Vidarabine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.00199	CcSEcCtD
Vidarabine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.00198	CcSEcCtD
Vidarabine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.00198	CcSEcCtD
Vidarabine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00197	CcSEcCtD
Vidarabine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00196	CcSEcCtD
Vidarabine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.00196	CcSEcCtD
Vidarabine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000172	0.00196	CcSEcCtD
Vidarabine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.00195	CcSEcCtD
Vidarabine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00195	CcSEcCtD
Vidarabine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000171	0.00194	CcSEcCtD
Vidarabine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00194	CcSEcCtD
Vidarabine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.00194	CcSEcCtD
Vidarabine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00017	0.00193	CcSEcCtD
Vidarabine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.00193	CcSEcCtD
Vidarabine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00017	0.00193	CcSEcCtD
Vidarabine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00017	0.00193	CcSEcCtD
Vidarabine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00017	0.00192	CcSEcCtD
Vidarabine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000169	0.00192	CcSEcCtD
Vidarabine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.00192	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.00192	CcSEcCtD
Vidarabine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000169	0.00191	CcSEcCtD
Vidarabine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.00191	CcSEcCtD
Vidarabine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.0019	CcSEcCtD
Vidarabine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.0019	CcSEcCtD
Vidarabine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.0019	CcSEcCtD
Vidarabine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000167	0.00189	CcSEcCtD
Vidarabine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000167	0.00189	CcSEcCtD
Vidarabine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.00189	CcSEcCtD
Vidarabine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.00189	CcSEcCtD
Vidarabine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00189	CcSEcCtD
Vidarabine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.00189	CcSEcCtD
Vidarabine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00188	CcSEcCtD
Vidarabine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.00188	CcSEcCtD
Vidarabine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00187	CcSEcCtD
Vidarabine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00187	CcSEcCtD
Vidarabine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000165	0.00187	CcSEcCtD
Vidarabine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.00186	CcSEcCtD
Vidarabine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.00185	CcSEcCtD
Vidarabine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00184	CcSEcCtD
Vidarabine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.00184	CcSEcCtD
Vidarabine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00184	CcSEcCtD
Vidarabine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.00182	CcSEcCtD
Vidarabine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.00182	CcSEcCtD
Vidarabine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00016	0.00182	CcSEcCtD
Vidarabine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.00181	CcSEcCtD
Vidarabine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.0018	CcSEcCtD
Vidarabine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.0018	CcSEcCtD
Vidarabine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.0018	CcSEcCtD
Vidarabine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.0018	CcSEcCtD
Vidarabine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.0018	CcSEcCtD
Vidarabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000158	0.0018	CcSEcCtD
Vidarabine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.0018	CcSEcCtD
Vidarabine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.00179	CcSEcCtD
Vidarabine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00179	CcSEcCtD
Vidarabine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.00179	CcSEcCtD
Vidarabine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000157	0.00178	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00178	CcSEcCtD
Vidarabine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.00178	CcSEcCtD
Vidarabine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000156	0.00177	CcSEcCtD
Vidarabine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.00177	CcSEcCtD
Vidarabine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.00177	CcSEcCtD
Vidarabine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00176	CcSEcCtD
Vidarabine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000155	0.00176	CcSEcCtD
Vidarabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00176	CcSEcCtD
Vidarabine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000155	0.00176	CcSEcCtD
Vidarabine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000155	0.00176	CcSEcCtD
Vidarabine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.00175	CcSEcCtD
Vidarabine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000154	0.00175	CcSEcCtD
Vidarabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000154	0.00174	CcSEcCtD
Vidarabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000153	0.00174	CcSEcCtD
Vidarabine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.00174	CcSEcCtD
Vidarabine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000153	0.00174	CcSEcCtD
Vidarabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000153	0.00174	CcSEcCtD
Vidarabine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.00174	CcSEcCtD
Vidarabine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00173	CcSEcCtD
Vidarabine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.00173	CcSEcCtD
Vidarabine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.00173	CcSEcCtD
Vidarabine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.00172	CcSEcCtD
Vidarabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000151	0.00171	CcSEcCtD
Vidarabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.00171	CcSEcCtD
Vidarabine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.0017	CcSEcCtD
Vidarabine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.0017	CcSEcCtD
Vidarabine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00169	CcSEcCtD
Vidarabine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.00168	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00168	CcSEcCtD
Vidarabine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.00168	CcSEcCtD
Vidarabine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.00168	CcSEcCtD
Vidarabine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000147	0.00167	CcSEcCtD
Vidarabine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000147	0.00167	CcSEcCtD
Vidarabine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00167	CcSEcCtD
Vidarabine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.00167	CcSEcCtD
Vidarabine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00166	CcSEcCtD
Vidarabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.00166	CcSEcCtD
Vidarabine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000146	0.00165	CcSEcCtD
Vidarabine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.00165	CcSEcCtD
Vidarabine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.00165	CcSEcCtD
Vidarabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.00165	CcSEcCtD
Vidarabine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.00164	CcSEcCtD
Vidarabine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00164	CcSEcCtD
Vidarabine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00164	CcSEcCtD
Vidarabine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.00162	CcSEcCtD
Vidarabine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00162	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.00161	CcSEcCtD
Vidarabine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.00161	CcSEcCtD
Vidarabine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.0016	CcSEcCtD
Vidarabine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.0016	CcSEcCtD
Vidarabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000141	0.0016	CcSEcCtD
Vidarabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000141	0.0016	CcSEcCtD
Vidarabine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.0016	CcSEcCtD
Vidarabine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00159	CcSEcCtD
Vidarabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.00159	CcSEcCtD
Vidarabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.00159	CcSEcCtD
Vidarabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.00158	CcSEcCtD
Vidarabine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.00158	CcSEcCtD
Vidarabine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000139	0.00158	CcSEcCtD
Vidarabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000139	0.00158	CcSEcCtD
Vidarabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.00158	CcSEcCtD
Vidarabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000139	0.00158	CcSEcCtD
Vidarabine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.00157	CcSEcCtD
Vidarabine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000138	0.00157	CcSEcCtD
Vidarabine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00157	CcSEcCtD
Vidarabine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00156	CcSEcCtD
Vidarabine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000137	0.00155	CcSEcCtD
Vidarabine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.00155	CcSEcCtD
Vidarabine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.00155	CcSEcCtD
Vidarabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.00154	CcSEcCtD
Vidarabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000136	0.00154	CcSEcCtD
Vidarabine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.00153	CcSEcCtD
Vidarabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.00153	CcSEcCtD
Vidarabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000135	0.00153	CcSEcCtD
Vidarabine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00153	CcSEcCtD
Vidarabine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000134	0.00153	CcSEcCtD
Vidarabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000134	0.00152	CcSEcCtD
Vidarabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.00152	CcSEcCtD
Vidarabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.00152	CcSEcCtD
Vidarabine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000134	0.00152	CcSEcCtD
Vidarabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000134	0.00152	CcSEcCtD
Vidarabine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00151	CcSEcCtD
Vidarabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.00151	CcSEcCtD
Vidarabine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000132	0.0015	CcSEcCtD
Vidarabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000132	0.0015	CcSEcCtD
Vidarabine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.0015	CcSEcCtD
Vidarabine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000132	0.00149	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.00149	CcSEcCtD
Vidarabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.00149	CcSEcCtD
Vidarabine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.00148	CcSEcCtD
Vidarabine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.00147	CcSEcCtD
Vidarabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.00147	CcSEcCtD
Vidarabine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.00147	CcSEcCtD
Vidarabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00146	CcSEcCtD
Vidarabine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.00145	CcSEcCtD
Vidarabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.00145	CcSEcCtD
Vidarabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.00144	CcSEcCtD
Vidarabine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000127	0.00144	CcSEcCtD
Vidarabine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000127	0.00144	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00143	CcSEcCtD
Vidarabine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000125	0.00142	CcSEcCtD
Vidarabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00141	CcSEcCtD
Vidarabine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.0014	CcSEcCtD
Vidarabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000124	0.0014	CcSEcCtD
Vidarabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.0014	CcSEcCtD
Vidarabine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.0014	CcSEcCtD
Vidarabine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.0014	CcSEcCtD
Vidarabine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.0014	CcSEcCtD
Vidarabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000123	0.00139	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.00137	CcSEcCtD
Vidarabine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.00136	CcSEcCtD
Vidarabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00135	CcSEcCtD
Vidarabine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.00135	CcSEcCtD
Vidarabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00134	CcSEcCtD
Vidarabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.00134	CcSEcCtD
Vidarabine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.00133	CcSEcCtD
Vidarabine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.00133	CcSEcCtD
Vidarabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00133	CcSEcCtD
Vidarabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.00132	CcSEcCtD
Vidarabine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.00132	CcSEcCtD
Vidarabine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.0013	CcSEcCtD
Vidarabine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.0013	CcSEcCtD
Vidarabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000114	0.00129	CcSEcCtD
Vidarabine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.00128	CcSEcCtD
Vidarabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.00127	CcSEcCtD
Vidarabine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00125	CcSEcCtD
Vidarabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.00125	CcSEcCtD
Vidarabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00124	CcSEcCtD
Vidarabine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000109	0.00123	CcSEcCtD
Vidarabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000109	0.00123	CcSEcCtD
Vidarabine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000108	0.00122	CcSEcCtD
Vidarabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.00122	CcSEcCtD
Vidarabine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.0012	CcSEcCtD
Vidarabine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.00119	CcSEcCtD
Vidarabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.00117	CcSEcCtD
Vidarabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.00117	CcSEcCtD
Vidarabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.00117	CcSEcCtD
Vidarabine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.00116	CcSEcCtD
Vidarabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.00116	CcSEcCtD
Vidarabine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000102	0.00116	CcSEcCtD
Vidarabine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.00116	CcSEcCtD
Vidarabine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00116	CcSEcCtD
Vidarabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.95e-05	0.00113	CcSEcCtD
Vidarabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.91e-05	0.00112	CcSEcCtD
Vidarabine—Rash—Delavirdine—acquired immunodeficiency syndrome	9.83e-05	0.00111	CcSEcCtD
Vidarabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.82e-05	0.00111	CcSEcCtD
Vidarabine—Headache—Delavirdine—acquired immunodeficiency syndrome	9.76e-05	0.00111	CcSEcCtD
Vidarabine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.75e-05	0.00111	CcSEcCtD
Vidarabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.67e-05	0.0011	CcSEcCtD
Vidarabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.53e-05	0.00108	CcSEcCtD
Vidarabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.00108	CcSEcCtD
Vidarabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.26e-05	0.00105	CcSEcCtD
Vidarabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.17e-05	0.00104	CcSEcCtD
Vidarabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.00104	CcSEcCtD
Vidarabine—Rash—Ritonavir—acquired immunodeficiency syndrome	9.09e-05	0.00103	CcSEcCtD
Vidarabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.00103	CcSEcCtD
Vidarabine—Headache—Ritonavir—acquired immunodeficiency syndrome	9.03e-05	0.00102	CcSEcCtD
Vidarabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.82e-05	0.001	CcSEcCtD
Vidarabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.75e-05	0.000992	CcSEcCtD
Vidarabine—Rash—Saquinavir—acquired immunodeficiency syndrome	8.75e-05	0.000992	CcSEcCtD
Vidarabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000991	CcSEcCtD
Vidarabine—Headache—Saquinavir—acquired immunodeficiency syndrome	8.69e-05	0.000986	CcSEcCtD
Vidarabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.56e-05	0.000971	CcSEcCtD
Vidarabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000954	CcSEcCtD
Vidarabine—Rash—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000946	CcSEcCtD
Vidarabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000945	CcSEcCtD
Vidarabine—Headache—Lamivudine—acquired immunodeficiency syndrome	8.29e-05	0.00094	CcSEcCtD
Vidarabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.24e-05	0.000934	CcSEcCtD
Vidarabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.86e-05	0.000891	CcSEcCtD
